F-598

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameF-598
Drug Alias NameF-598SAR-279356
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionPoly-N-acetyl glucosamine inhibitorsSurface antigens inhibitors
TargetsSurface antigensPoly-N-acetyl glucosamine
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlopexx Oncology Llc
China Registration ClassN/A

Develop Information

Active CompaniesSanofi-Aventis GroupeAlopexx Oncology Llc
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A